1 enrolling by invitation, 1 not yet recruiting, 1 unknown. 3 Phase 3.
| Phase | Trials | Status |
|---|---|---|
| Phase 3 | 3 | Enrolling by invitation 1, Not yet recruiting 1, Unknown 1 |
Follow Ketorolac: new trials by email Literature Review of Ketorolac trials Research Report on Ketorolac
Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.
| Trial | Phase | Status | Sponsor | Enrollment | Start | Updated |
|---|---|---|---|---|---|---|
| Atomized Intranasal Ketorolac at 30 mg Versus 20 mg for the Treatment of Acute Pain in the Emergency Department 20mg intranasal ketorolac, 30mg Intranasal Ketorolac - Pain, Ketorolac | Phase 3 | Not yet recruiting | Tehran University of Medical Sciences | 100 | 2026-10-10 | 2026-09-16 |
| NSAIDS Following Elective Lumbar Spine Fusion Ketorolac, Naproxen, Standard Postoperative Pain Management - NSAID (Non-Steroidal Anti-Inflammatory Drug), Lumbar Spine Fusion | Phase 3 | Enrolling by invitation | Rothman Institute Orthopaedics | 428 | 2024-07-08 | 2026-08-04 |
| Effect of Postoperative Ketorolac on Bone Healing After Joint Fusion great toe (1st metatarsophalangeal joint) fusion, IV Ketorolac, Ketorolac Pill - Ketorolac, Joint Fusion | Phase 3 | Unknown | Rothman Institute Orthopaedics | 140 | 2019-05-23 | 2021-05-04 |
Ankylosis (1) · Emergencies (1) · Pain (1) · Pain, Postoperative (1)
Neurologic Manifestations (2) · Pathologic Processes (2) · Pathological Conditions, Signs and Symptoms (2) · Signs and Symptoms (2) · Disease Attributes (1) · Joint Diseases (1) · Musculoskeletal Diseases (1) · Pain (1) · Postoperative Complications (1)
Ketorolac (2) · Aspirin (1) · Gene Fusion (1) · Naproxen (1) · oxycodone-acetaminophen (1)
Rothman Institute Orthopaedics (2) · Tehran University of Medical Sciences (1)
United States (2)